The final, formatted version of the article will be published soon.
ORIGINAL RESEARCH article
Front. Endocrinol.
Sec. Renal Endocrinology
Volume 16 - 2025 |
doi: 10.3389/fendo.2025.1416506
This article is part of the Research Topic Identification of Effective Biomarkers for Diagnosis and Treatment of Chronic Kidney Disease: Integrating Bioinformatics and Pharmacological Approaches View all 4 articles
.1 Nonlinear Association Between Glycated Hemoglobin Levels and Mortality in Elderly Patients with Non-Diabetic Chronic Kidney Disease: A National Health and Nutrition Examination Survey Analysis
Provisionally accepted- The Second Affiliated Hospital of Gannan Medical University, Ganzhou, China
Background: The relationship between glycated hemoglobin (HbA1c) levels and mortality outcomes in elderly patients with non-diabetic chronic kidney disease (CKD) has not been well characterized.This study aimed to investigate the correlation between HbA1c levels and all-cause and cardiovascular disease (CVD) mortality in elderly individuals with non-diabetic CKD.Methods: Data from the NHANES (1999)(2000)(2001)(2002)(2003)(2004)(2005)(2006)(2007)(2008)(2009)(2010)(2011)(2012)(2013)(2014)(2015)(2016)(2017)(2018) were analyzed to measure HbA1c levels in whole blood using high-performance liquid chromatography (HPLC). Information on deaths and subsequent details was collected through the National Mortality Index until December 31, 2019. Hazard ratios (HR) and 95% confidence intervals (CIs) for all-cause and CVD mortality were calculated using weighted Cox proportional hazards and restricted cubic spline models.2 Results: Among the 1,931 participants (mean [SE] age, 73.2 [0.2] years; 61.9% female), over a median follow-up period of 7.6 years, a total of 1,003 deaths were observed, including 412 from CVD. HbA1c was divided into four quartiles: Quartile 1 (3.7-5.3%), Quartile 2 (5.4-5.6%), Quartile 3 (5.7-5.8%) as the reference group, and Quartile 4 (5.9-6.4%). Higher risks of all-cause mortality were noted in the lowest and highest HbA1c quartiles, with adjusted HR (95% CI) of 1.48 (1.18-1.87) and 1.31 (1.01-1.70) respectively. For CVD mortality, the lowest quartile showed a significantly increased risk (HR 1.94, 95% CI: 1.29-2.90), but the highest quartile did not significantly differ from the reference, with HR 1.14 (0.73-1.77). The RCS analysis indicated a U-shaped nonlinear relationship between HbA1c levels and all-cause mortality (P = 0.026 for nonlinearity) and a Jshaped nonlinear relationship with CVD mortality (P = 0.035 for nonlinearity).Conclusion: This cohort study suggests that both low and high HbA1c levels are associated with an increased risk of all-cause mortality in elderly patients with non-diabetic CKD.
Keywords: Chronic Kidney Disease, Non-diabetic, Mortality, HbA1c, NHANES
Received: 12 Apr 2024; Accepted: 22 Jan 2025.
Copyright: © 2025 HUANG, He, Zeng, Huang, Luo and Zhong. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Liuliu He, The Second Affiliated Hospital of Gannan Medical University, Ganzhou, China
Jinjing Huang, The Second Affiliated Hospital of Gannan Medical University, Ganzhou, China
Xiaoyan Luo, The Second Affiliated Hospital of Gannan Medical University, Ganzhou, China
Qiuming Zhong, The Second Affiliated Hospital of Gannan Medical University, Ganzhou, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.